1WM
GILD icon

1858 Wealth Management’s Gilead Sciences GILD Stock Holding History

1858 Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-9,310
Closed -$754K – 128
2024
Q1 		$754K Hold
9,310
– – 0.72% 43
2023
Q4 		$754K Buy
+9,310
New +$724K 0.72% 43

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

1858 Wealth Management's GILD Position: Q2 2024 in Review

1858 Wealth Management sold out of Gilead Sciences (GILD) in Q2 2024, closing a stake of 9,310 shares — an estimated $754K sold.

1858 Wealth Management first reported a position in GILD in Q4 2023 and held it in 2 quarters. The position peaked at $754K in Q1 2024. 1,679 funds tracked by Wall St. Rank hold GILD as of Q2 2024.

  • 1858 Wealth Management reported no remaining Gilead Sciences position as of Q2 2024 after selling out during the quarter.
  • 1858 Wealth Management sold 9,310 Gilead Sciences shares in Q2 2024, an estimated $754K.
  • 1858 Wealth Management first reported a position in Gilead Sciences in Q4 2023 and held it in 2 quarters.
  • 1858 Wealth Management's Gilead Sciences position peaked at $754K in Q1 2024.
  • 1,679 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2024.

Based on 1858 Wealth Management's 13F filing for Q2 2024, filed 18 Jul 2024.